These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23770421)

  • 1. Molecular and pharmacological characterization of zebrafish 'relaxant' prostanoid receptors.
    Tsuge K; Iwasaki R; Morimoto K; Inazumi T; Kawahara O; Kawahara A; Tsuchiya S; Sugimoto Y
    Biochem Biophys Res Commun; 2013 Jul; 436(4):685-90. PubMed ID: 23770421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and pharmacological characterization of zebrafish 'contractile' and 'inhibitory' prostanoid receptors.
    Iwasaki R; Tsuge K; Morimoto K; Inazumi T; Kawahara O; Kawahara A; Tsuchiya S; Sugimoto Y
    Biochem Biophys Res Commun; 2013 Aug; 438(2):353-8. PubMed ID: 23892039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells.
    Kiriyama M; Ushikubi F; Kobayashi T; Hirata M; Sugimoto Y; Narumiya S
    Br J Pharmacol; 1997 Sep; 122(2):217-24. PubMed ID: 9313928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
    Watanabe T; Satoh H; Togoh M; Taniguchi S; Hashimoto Y; Kurokawa K
    J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist.
    Whittle BJ; Silverstein AM; Mottola DM; Clapp LH
    Biochem Pharmacol; 2012 Jul; 84(1):68-75. PubMed ID: 22480736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin receptor signaling in disease.
    Matsuoka T; Narumiya S
    ScientificWorldJournal; 2007 Sep; 7():1329-47. PubMed ID: 17767353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activation Mechanism of Prostanoid Receptors -X-ray Crystallography of EP3 Receptor].
    Morimoto K
    Yakugaku Zasshi; 2021; 141(4):473-479. PubMed ID: 33790113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostanoid receptor subtypes.
    Tsuboi K; Sugimoto Y; Ichikawa A
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():535-56. PubMed ID: 12432942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostanoid receptors involved in the relaxation of human pulmonary vessels.
    Walch L; Labat C; Gascard JP; de Montpreville V; Brink C; Norel X
    Br J Pharmacol; 1999 Feb; 126(4):859-66. PubMed ID: 10193765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of cAMP production and cyclooxygenase-2 by prostaglandin E(2) and selective prostaglandin receptor agonists in murine osteoblastic cells.
    Sakuma Y; Li Z; Pilbeam CC; Alander CB; Chikazu D; Kawaguchi H; Raisz LG
    Bone; 2004 May; 34(5):827-34. PubMed ID: 15121014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of prostaglandin F receptor (FP) and E receptor subtype 1 (EP₁) in zebrafish.
    Kwok AH; Wang Y; Leung FC
    Gen Comp Endocrinol; 2012 Sep; 178(2):216-26. PubMed ID: 22617193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and expression of a cDNA for the human prostanoid IP receptor.
    Boie Y; Rushmore TH; Darmon-Goodwin A; Grygorczyk R; Slipetz DM; Metters KM; Abramovitz M
    J Biol Chem; 1994 Apr; 269(16):12173-8. PubMed ID: 7512962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostanoid-induced relaxation of precontracted cat ciliary muscle is mediated by EP2 and DP receptors.
    Chen J; Woodward DF
    Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3195-201. PubMed ID: 1328113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2.
    Fujino H; Salvi S; Regan JW
    Mol Pharmacol; 2005 Jul; 68(1):251-9. PubMed ID: 15855407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostanoids receptors signaling in different diseases/cancers progression.
    Yang Y; Tang LQ; Wei W
    J Recept Signal Transduct Res; 2013; 33(1):14-27. PubMed ID: 23327583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of prostanoid IP and EP receptors in mediating vasorelaxant responses to PGI2 analogues in rat tail artery: Evidence for Gi/o modulation via EP3 receptors.
    Orie NN; Clapp LH
    Eur J Pharmacol; 2011 Mar; 654(3):258-65. PubMed ID: 21185823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and molecular pharmacology of the mouse CRTH2 receptor.
    Hata AN; Zent R; Breyer MD; Breyer RM
    J Pharmacol Exp Ther; 2003 Aug; 306(2):463-70. PubMed ID: 12721327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures.
    Minamizaki T; Yoshiko Y; Kozai K; Aubin JE; Maeda N
    Bone; 2009 Jun; 44(6):1177-85. PubMed ID: 19233324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of extracellular cysteine residues in dimerization/oligomerization of the human prostacyclin receptor.
    Giguère V; Gallant MA; de Brum-Fernandes AJ; Parent JL
    Eur J Pharmacol; 2004 Jun; 494(1):11-22. PubMed ID: 15194446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.